XLR-12

XLR-12 is an indole-based synthetic cannabinoid drug that was invented by Abbott Laboratories in 2006.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

XLR-12 is an indole-based synthetic cannabinoid drug that was invented by Abbott Laboratories in 2006. It is an analogue of XLR-11 where the 5-fluoropentyl chain has been replaced with a 4,4,4-trifluorobutyl chain. XLR-12 is relatively highly selective for the CB 2 receptor, with a K i of 0.09 nM and 167x selectivity over the related CB 1 receptor, however it still retains appreciable affinity for CB 1 with a K i of 15 nM.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1332233314 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.